K H Jakobs

3.5k total citations
48 papers, 3.0k citations indexed

About

K H Jakobs is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, K H Jakobs has authored 48 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 13 papers in Cellular and Molecular Neuroscience and 9 papers in Physiology. Recurrent topics in K H Jakobs's work include Receptor Mechanisms and Signaling (21 papers), Neuropeptides and Animal Physiology (9 papers) and Protein Kinase Regulation and GTPase Signaling (8 papers). K H Jakobs is often cited by papers focused on Receptor Mechanisms and Signaling (21 papers), Neuropeptides and Animal Physiology (9 papers) and Protein Kinase Regulation and GTPase Signaling (8 papers). K H Jakobs collaborates with scholars based in Germany, France and United States. K H Jakobs's co-authors include Klaus Aktories, Peter Gierschik, G. Schultz, Iwao Ohishi, M. Bärmann, E. Habermann, Shingo Tsuyama, B. Cantau, Serge Jard and Thomas Wieland and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

K H Jakobs

48 papers receiving 2.8k citations

Peers

K H Jakobs
Y Matsuda Japan
Lisa M. Ballou United States
N D Goldberg United States
Daniel C. Devor United States
Graeme B. Bolger United States
Derrick R. Witcher United States
Steven R. Post United States
Catherine M. Fuller United States
Ben C. Tilly Netherlands
Y Matsuda Japan
K H Jakobs
Citations per year, relative to K H Jakobs K H Jakobs (= 1×) peers Y Matsuda

Countries citing papers authored by K H Jakobs

Since Specialization
Citations

This map shows the geographic impact of K H Jakobs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K H Jakobs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K H Jakobs more than expected).

Fields of papers citing papers by K H Jakobs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K H Jakobs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K H Jakobs. The network helps show where K H Jakobs may publish in the future.

Co-authorship network of co-authors of K H Jakobs

This figure shows the co-authorship network connecting the top 25 collaborators of K H Jakobs. A scholar is included among the top collaborators of K H Jakobs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K H Jakobs. K H Jakobs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schmidt, Martina, Carsten Sand, K H Jakobs, Martin C. Michel, & Paschal A. Oude Weernink. (2007). Epac and the cardiovascular system. Current Opinion in Pharmacology. 7(2). 193–200. 41 indexed citations
2.
Rümenapp, Ulrich, G. Lümmen, Sebastian Virchow, et al.. (2000). Sphingolipid receptor signaling and function in human bladder carcinoma cells: inhibition of LPA- but enhancement of thrombin-stimulated cell motility. Naunyn-Schmiedeberg s Archives of Pharmacology. 361(1). 1–11. 19 indexed citations
3.
Vögler, Oliver, et al.. (1999). RhoA-Sensitive Trafficking of Muscarinic Acetylcholine Receptors. Journal of Pharmacology and Experimental Therapeutics. 288(1). 36–42. 23 indexed citations
4.
Wagner, Stephan N., et al.. (1996). Inhibition of T cell cAMP formation by cyclosporin A and FK506. Naunyn-Schmiedeberg s Archives of Pharmacology. 353(5). 513–6. 7 indexed citations
5.
Lenz, W., et al.. (1996). Receptor internalization delays m4 muscarinic acetylcholine receptor resensitization at the plasma membrane.. Molecular Pharmacology. 50(2). 424–429. 37 indexed citations
6.
Siffert, Winfried, Dieter Rosskopf, Albrecht Moritz, et al.. (1995). Enhanced G protein activation in immortalized lymphoblasts from patients with essential hypertension.. Journal of Clinical Investigation. 96(2). 759–766. 159 indexed citations
7.
Bünemann, Moritz, Bodo Brandts, Dagmar Meyer zu Heringdorf, et al.. (1995). Activation of muscarinic K+ current in guinea‐pig atrial myocytes by sphingosine‐1‐phosphate.. The Journal of Physiology. 489(3). 701–707. 101 indexed citations
8.
Wieland, Thomas, Peter Gierschik, & K H Jakobs. (1992). G protein-mediated receptor-receptor interaction: studies with chemotactic receptors in membranes of human leukemia (HL 60) cells. Naunyn-Schmiedeberg s Archives of Pharmacology. 346(5). 475–81. 9 indexed citations
9.
Gachet, Christian, Pierre Savi, Philippe Ohlmann, et al.. (1992). ADP Receptor Induced Activation of Guanine Nucleotide Binding Proteins in Rat Platelet Membranes– An Effect Selectively Blocked by the Thienopyridine Clopidogrel. Thrombosis and Haemostasis. 68(1). 79–83. 34 indexed citations
10.
Reithmann, Christopher, Peter Gierschik, Karl Werdan, & K H Jakobs. (1991). Role of inhibitory G protein α-subunits in adenylyl cyclase desensitization. Molecular and Cellular Endocrinology. 82(2-3). C215–C221. 17 indexed citations
11.
Reithmann, Christopher, Peter Gierschik, K H Jakobs, & Karl Werdan. (1991). Regulation of adenylyl cyclase by noradrenaline and tumour necrosis factor   in rat cardiomyocytes. European Heart Journal. 12(suppl F). 139–142. 30 indexed citations
13.
Wieland, Thomas, Isabel Ulibarri, Peter Gierschik, et al.. (1990). Interaction of recombinant rho A GTP‐binding proteins with photoexcited rhodopsin. FEBS Letters. 274(1-2). 111–114. 18 indexed citations
14.
Gierschik, Peter, Dimitrios N. Sidiropoulos, & K H Jakobs. (1989). Two distinct Gi-proteins mediate formyl peptide receptor signal transduction in human leukemia (HL-60) cells. Journal of Biological Chemistry. 264(36). 21470–21473. 158 indexed citations
15.
Gierschik, Peter, Kenneth R. McLeish, & K H Jakobs. (1988). Regulation of G-Protein-Mediated Signal Transfer by Ions. Journal of Cardiovascular Pharmacology. 12(Supplement). 20–24. 15 indexed citations
16.
Hekman, Mirko, Peter Gierschik, Mie‐Jae Im, et al.. (1987). Regulation of signal transfer from beta1-adrenoceptor to adenylate cyclase by betagamma subunits in a reconstituted system. European Journal of Biochemistry. 169(2). 431–439. 58 indexed citations
17.
Aktories, Klaus, et al.. (1986). Evidence for two GTPases activated by thrombin in membranes of human platelets. Biochemical Journal. 237(3). 669–674. 48 indexed citations
18.
Jakobs, K H, et al.. (1986). Dual regulation of adenylate cyclase. A signal transduction mechanism of membrane receptors. Basic Research in Cardiology. 81(1). 1–9. 61 indexed citations
19.
Jakobs, K H, et al.. (1982). Acceleration of the adipocyte adenylate cyclase turn-off reaction by inhibitory hormonal factors.. Proceedings of the National Academy of Sciences. 79(5). 1373–1377. 8 indexed citations
20.
Jakobs, K H. (1979). Inhibition of adenylate cyclase by hormones and neurotransmitters. Molecular and Cellular Endocrinology. 16(3). 147–156. 156 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026